Patents Represented by Attorney Ropes & Gray, LLP
-
Patent number: 7713915Abstract: A method is provided for constructing, identifying and using new therapeutic or diagnostic proteins capable of binding to a target cell. The new proteins are derived by mutating a binding subunit of a wild type heteromeric cytotoxic protein to create a library of microorganism clones producing mutant proteins which are then screened for their ability to specifically bind to and kill a target cell.Type: GrantFiled: December 8, 1998Date of Patent: May 11, 2010Assignee: Molecular Templates, Inc.Inventors: Jean Gariepy, Mark Robert Bray
-
Patent number: 7666646Abstract: The present invention relates to the X-ray analysis of crystalline molecules or molecular complexes of human Pim-1. The present invention also relates to Pim-1-like binding pockets. The present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Pim-1 protein, Pim-1 protein complexes, or homologues thereof. The invention also relates to crystallizable compositions and crystals comprising Pim-1 protein, Pim-1 protein complexes with adenosine, staurosporine or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one and methods to produce these crystals.Type: GrantFiled: October 4, 2005Date of Patent: February 23, 2010Assignee: Vertex Pharmaceuticals IncorporatedInventors: Marc Jacobs, Brian Hare, Lovorka Swenson
-
Patent number: 7637809Abstract: Ticketing systems and methods are provided specifically relating to a player's ticket. A player's ticket references at least one player and allows the player's ticket holder to attend all sporting events played in by the at least one player referenced on the player's ticket. Information about a tournament, including the players, the tournament draw, and historical data, is acquired and used to determine the probabilities of players winning matches in the tournament. Different possible allocations of admissions (e.g., seats) for player's tickets to matches of the tournament are determined based on the tournament draw and how many player's tickets are provided for the matches. One of the allocations of seats of the possible allocations is chosen based on the probabilities of players winning matches in the tournament which aids in determining the likelihood of accommodating all player's ticket holders for each match.Type: GrantFiled: April 8, 2005Date of Patent: December 29, 2009Inventor: Sharad A Ghosh
-
Patent number: 7634786Abstract: An interactive television program guide system for determining user input values for demographic categories is provided. The system includes user television equipment having a receiver for receiving program guide information for the interactive television program guide, a user input receiver for receiving user input from user interface, a microprocessor which utilizes the user input received to determine user values for demographic categories, and memory for storing the user values determined. In one illustrative use of the system for targeting advertisements the receiver also receives advertisements, where the advertisements have preselected values for specified demographic categories. The user television equipment, preferably using a microprocessor, compares the preselected values for the specified demographic categories associated with the advertisements with values of corresponding demographic categories stored in memory to determine which advertisements should be displayed.Type: GrantFiled: August 20, 2004Date of Patent: December 15, 2009Assignee: United Video Properties, Inc.Inventors: Robert A Knee, Steven J Reynolds, Michael D Ellis, Joel G Hassell
-
Patent number: 7624410Abstract: A program guide system is provided that supports a program guide application and multiple non-guide applications. The program guide system has a program guide application interface that allows the non-guide applications to use both device resources and program guide resources. The application interface maintains a list of registered applications and directs control requests from various applications to the current primary application. The application interface also has a user interface input director that directs keystrokes and other user input commands to the appropriate application. If a keystroke for the program guide application is detected while a non-guide application is running, the program guide application is invoked.Type: GrantFiled: October 10, 2003Date of Patent: November 24, 2009Assignee: United Video Properties, Inc.Inventors: Michael D Ellis, Robert A Knee
-
Patent number: 7457807Abstract: A data migration technique presumes a schema suitable for combining disparate data sources in a business environment. This presumptive approach to data migration permits the development of rules and libraries specifically adapted to move data from various sources into the schema, and advantageously permits formal realization of experience that has been developed over years of work in translating various data sets to the schema. As a result, data migration can become highly automated, and the timeline for migration can be reduced from months to days or hours. This approach also permits the creation of universal analytical business tools that operate from the fixed, presumptive schema.Type: GrantFiled: January 8, 2004Date of Patent: November 25, 2008Assignee: Oco I, Inc.Inventor: George W. O'Conor
-
Patent number: 7427665Abstract: A CLL line, CLL-AAT, and the preparation and characterization of antibodies using said cell line is disclosed.Type: GrantFiled: December 10, 2001Date of Patent: September 23, 2008Assignee: Alexion Pharmaceuticals, Inc.Inventors: Katherine S. Bowdish, John McWhirter
-
Patent number: 7414111Abstract: Methods of amplifying nucleic acid have now been discovered which include the steps of: a) annealing a primer to a template nucleic acid sequence, the primer having a first portion which anneals to the template and a second portion of predetermined sequence; b) synthesizing a polynucleotide that anneals to and is complementary to the portion of the template between the location at which the first portion of the primer anneals to the template and the end of the template, the polynucleotide having a first end and a second end, wherein the first end incorporates the primer; c) separating the polynucleotide synthesized in step (b) from the template; d) annealing a nested oligonucleotide to the second end of the polynucleotide synthesized in step (b), the nested oligonucleotide having a first portion that anneals to the second end of the polynucleotide and a second portion having the same predetermined sequence as the second portion of the primer; e) extending the polynucleotide synthesized in step (b) to provideType: GrantFiled: December 15, 2003Date of Patent: August 19, 2008Assignee: Alexion Pharmaceuticals, Inc.Inventors: Toshiaki Maruyama, Katherine S. Bowdish, Shana Frederickson, Mark Renshaw
-
Patent number: 7408041Abstract: Cancer treatments use a therapy that: 1) interferes with the interaction between CD200 and its receptor to block immune suppression thereby promoting eradication of the cancer cells; and 2) directly kills the cancer cells either by complement-mediated or antibody-dependent cellular cytotoxicity or by targeting cells using a fusion molecule that includes a CD200-targeting portion. The therapy includes the administration of novel antibodies, functional fragments thereof or fusion molecules containing portions thereof.Type: GrantFiled: November 23, 2004Date of Patent: August 5, 2008Assignee: Alexion Pharmaceuticals, Inc.Inventors: Katherine S. Bowdish, John McWhirter, Anke Kretz-Rommel, Toshiaki Maruyama
-
Patent number: 7371920Abstract: The present invention provides a transgenic animal model of Alzheimer's Disease designated TgCRND8 as well as a method for making such model, which allows for the characterization of the etiology of the disease as well as for provide a system for the development and testing of potential treatments.Type: GrantFiled: June 19, 2001Date of Patent: May 13, 2008Assignee: The Governing Council of the University of TorontoInventors: Peter H. St. George-Hyslop, Paul E. Fraser, David Westaway
-
Patent number: 7371570Abstract: Replication-competent adenoviral vectors comprising an EBV-specific transcriptional regulatory element (TRE) operably linked to a gene required for adenovirus replication are provided. By providing for transcriptional initiating regulation dependent upon transcription factors that are only active in specific, limited cell types, virus replication can be restricted to particular target cells. The modified adenovirus may be used as a vehicle for introducing new genetic capability, particularly associated with cytotoxicity for treating neoplasia.Type: GrantFiled: October 30, 2003Date of Patent: May 13, 2008Assignee: Cell Genesys, Inc.Inventors: De Chao Yu, Nagarajan Ramesh
-
Patent number: 7370380Abstract: A mattress is constructed from a mattress body having an upper and a lower deck, which is preferably pervious to moisture and air. A removable panel, which includes a top layer of breathable fabric, a bottom layer of a fabric that forms a moisture barrier, and a batting layer, is placed on at least the upper deck of the mattress body. The removable panel is removably attached along the perimeter of the deck or decks by a fastener, such as a zipper. The panel can be removed from the deck for cleaning and folded and secured by the fastener in an inverted configuration, with the top layer facing outward.Type: GrantFiled: July 18, 2005Date of Patent: May 13, 2008Assignee: Dreamwell, Ltd.Inventors: Michael S. DeFranks, Kurtis A. Ling, Joyce A. Handley, James R. Peavyhouse, Ruben M. Ortiz
-
Patent number: 7365189Abstract: The present invention relates to nucleic acid molecules encoding enzymes which are involved in the starch synthesis in plants. These enzymes are starch synthases from wheat. The invention further relates to vectors and host cells containing said nucleic acid molecules, in particular transformed plant cells and plants regenerated from these cells, which exhibit an increased or a reduced activity of the described starch synthases.Type: GrantFiled: April 5, 2004Date of Patent: April 29, 2008Assignee: Hoechst Schering AgrEvo GmbHInventors: Martina Block, Horst Lorz, Stephanie Lutticke, Lennart Walter, Claus Frohberg, Jens Kossmann
-
Patent number: 7364727Abstract: Colon cancer specific promoter sequences and adenovirus vehicles are provided. By providing for transcriptional initiating regulation dependent upon transcription factors that are only active in specific, limited cell types, virus replication will be restricted to the target cells. The modified adenovirus may be used as a vehicle for introducing new genetic capability, particularly associated with cytotoxicity for treating neoplasia.Type: GrantFiled: July 21, 2003Date of Patent: April 29, 2008Assignee: Cell Genesys, Inc.Inventors: Yuanhao Li, De-Chao Yu
-
Patent number: 7361492Abstract: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.Type: GrantFiled: November 1, 2004Date of Patent: April 22, 2008Assignee: Vertex Pharmaceuticals IncorporatedInventors: Graham Cheetham, Ronald Knegtel, Lovorka Swenson, Joyce T. Coll, Suzanne Renwick, Peter Weber
-
Patent number: 7351798Abstract: This invention relates to methods for the stabilization, storage and delivery of biologically active macromolecules, such as proteins, peptides and nucleic acids. In particular, this invention relates to protein or nucleic acid crystals, formulations and compositions comprising them. Methods are provided for the crystallization of proteins and nucleic acids and for the preparation of stabilized protein or nucleic acid crystals for use in dry or slurry formulations. The present invention is further directed to encapsulating proteins, glycoproteins, enzymes, antibodies, hormones and peptide crystals or crystal formulations into compositions for biological delivery to humans and animals. According to this invention, protein crystals or crystal formulations are encapsulated within a matrix comprising a polymeric carrier to form a composition.Type: GrantFiled: March 5, 2003Date of Patent: April 1, 2008Assignee: Altus Pharmaceuticals Inc.Inventors: Alexey L Margolin, Nazar K Khalaf, Nancy L St Clair, Scott L Rakestraw, Bhami C Shenoy
-
Patent number: 7319033Abstract: Replication-competent adenovirus vectors specific for cells which allow a probasin transcriptional response element (PB-TRE) to function, such as cells which express the androgen receptor (AR), and methods of use of such viruses are provided. These viruses comprise an adenoviral gene under control of a transcriptional regulatory portion of a PB-TRE, which is in turn dependent upon AR expression. The gene can be, for example, a gene required for viral replication or the adenovirus death protein gene (ADP). The viruses can also comprise at least one additional adenoviral gene under control of at least one additional prostate-specific transcriptional response element, such as that controlling prostate-specific antigen expression (PSA-TRE). Thus, virus replication can be restricted to target cells exhibiting prostate-specific gene expression, particularly prostate carcinoma cells.Type: GrantFiled: August 16, 2002Date of Patent: January 15, 2008Assignee: Cell Genesys, Inc.Inventors: Daniel R. Henderson, Eric R. Schuur, De-Chao Yu
-
Patent number: 7309906Abstract: Improved decoupling capacitor designs and layout schemes are provided that generate high effective capacitance and high area efficiency at higher frequencies than that of previously known decoupling capacitor designs. The improved decoupling capacitor designs utilize transistor gates with shorter channel lengths to reduce the total parasitic resistance of the channel, thereby providing higher effective capacitance at higher frequencies. To enable higher area efficiency of this decoupling capacitor design, excess contacts are replaced with polysilicon in a grid or waffle pattern.Type: GrantFiled: April 1, 2005Date of Patent: December 18, 2007Assignee: Altera CorporationInventors: Jeffrey Tyhach, Bonnie I Wang, Yan Chong, Chiakang Sung
-
Patent number: 7306506Abstract: Chemical-mechanical planarization (CMP) apparatus and methods for detecting polishing pad properties using ultrasonic imaging is presented. An ultrasonic probe assembly transmits ultrasonic signals onto the surface of a polishing pad during a CMP process. Reflected ultrasonic signals are collected and analyzed to monitor polishing pad properties in real-time. This allows CMP process adjustments to be made during the CMP process.Type: GrantFiled: March 15, 2007Date of Patent: December 11, 2007Assignee: Micron Technology, Inc.Inventor: Jason B. Elledge
-
Patent number: 7267815Abstract: Agents and methods for enhancing recombinant virus transduction in the bladder epithelium are described. A first method involves contacting the luminal surface of the bladder with a composition comprising a transduction enhancing agent and an oncolytic virus. Alternatively, the luminal surface of the bladder can be contacted first with a pretreatment composition comprising a transduction enhancing agent and, subsequently, with a composition comprising an oncolytic virus. Bladder treatment compositions comprising a transduction enhancing agent and an oncolytic virus are also described.Type: GrantFiled: December 24, 2003Date of Patent: September 11, 2007Assignee: Cell Genesys, Inc.Inventors: Nagarajan Ramesh, David Frey, Bahram Memarzadeh, DeChao Yu